Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Common Stock | Award | $3.53M | +4.79K | +31.91% | $737.26 | 19.8K | Feb 12, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | LLY | Restricted Stock Unit | Award | $0 | +3.27K | $0.00 | 3.27K | Feb 12, 2024 | Common Stock | 3.27K | Direct | F1 |
Id | Content |
---|---|
F1 | Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock. |